Helicobacter pylori and bleeding peptic ulcer: what is the prevalence of the infection in patients with this complication?
Gisbert
J P
JP
Dept. of Gastroenterology, University Hospital of La Princesa, Madrid, Spain.
Pajares
J M
JM
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination / Q000627:therapeutic use; D016099:Endoscopy, Gastrointestinal; D016021:Epidemiologic Studies; D016481:Helicobacter Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology*; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D010438:Peptic Ulcer Hemorrhage / Q000188:drug therapy / Q000453:epidemiology* / Q000209:etiology; D015995:Prevalence
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents